Examkin

Question

Difficulty: MediumInfectious Diseases

An 82-year-old man residing in a long-term care facility is evaluated during a routine monthly visit. The facility staff report that over the past two days, his urine collection bag has contained visibly cloudy and notably malodorous urine. He has a chronic indwelling urethral catheter that was placed six months ago for severe urinary retention secondary to advanced benign prostatic hyperplasia. The patient currently has no complaints. He denies chills, abdominal discomfort, or flank pain. His appetite is normal, and he has been actively participating in his usual group activities. His temperature is 37.1°C (98.8°F), blood pressure is 130/80 mm Hg, heart rate is 76/min, and respiratory rate is 14/min. Physical examination reveals a soft, non-tender abdomen with no costovertebral angle tenderness. The urethral meatus shows no erythema or purulent discharge. A urinalysis obtained by the staff earlier today demonstrates positive leukocyte esterase, positive nitrites, and 45 leukocytes/hpf. Which of the following is the most appropriate next step in management?

  1. Observation without antimicrobial therapyAnswer
  2. B
    Empiric oral ciprofloxacin
  3. C
    Catheter exchange and empiric oral trimethoprim-sulfamethoxazole
  4. D
    Continuous bladder irrigation with an antimicrobial solution
  5. E
    Empiric intravenous ceftriaxone

Answer

Observation without antimicrobial therapy
The correct approach is observation without antimicrobial therapy. This patient presents with cloudy, malodorous urine and urinalysis findings consistent with bacteriuria and pyuria. However, he lacks any systemic symptoms (such as fever, rigors, or altered mental status) or localizing signs (such as flank pain or suprapubic tenderness). In patients with a chronic indwelling Foley catheter, bacterial colonization of the bladder and catheter biofilm is ubiquitous and inevitable. Cloudy or foul-smelling urine alone, even with pyuria, is not an indication for testing or treatment in an asymptomatic patient. According to established antibiotic stewardship guidelines, screening for and treating asymptomatic bacteriuria in this population provides no clinical benefit and actively harms the patient by increasing the risk of adverse drug reactions, Clostridioides difficile infection, and the emergence of multi-drug resistant organisms.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient is afebrile, hemodynamically stable, has no localizing signs of infection (no flank or abdominal pain), and is participating in normal daily activities.
Establishing the presence or absence of systemic signs of infection is critical to differentiate asymptomatic bacteriuria from a true urinary tract infection.
2
Evaluate the laboratory findings in the context of a chronic indwelling catheter.
Urinalysis shows pyuria and bacteriuria (cloudy, foul-smelling urine with positive leukocyte esterase and nitrites), which is an expected finding in chronically catheterized patients due to universal biofilm formation and colonization.
Pyuria and malodorous urine do not independently confirm a symptomatic infection in catheterized patients; they merely confirm colonization.
3
Determine the appropriate management based on antibiotic stewardship guidelines.
Because the patient is asymptomatic, the diagnosis is asymptomatic bacteriuria. The standard of care is to avoid antibiotics.
Treating asymptomatic bacteriuria does not improve clinical outcomes and leads to antimicrobial resistance, drug toxicity, and an increased risk of Clostridioides difficile infections.

Key Concept

Management of asymptomatic bacteriuria in chronically catheterized patients
Rate this question

Topics

Infectious Diseases

More questions from this topic